Market research firm Omdia has released a report indicating that the Chinese generative artificial intelligence (GenAI) software market is experiencing rapid growth. The report shows that by 2024, China's GenAI software revenue is expected to reach $1.8 billion, approximately 13.1 billion yuan. This market is still in its infancy, but the development potential over the next five years is enormous, with the market size projected to grow 5.5 times, reaching $9.8 billion by 2029, approximately 71.4 billion yuan. Omdia's report emphasizes

The global AI medical imaging market is projected to reach $29.8 billion by 2032. North America holds the largest market share, but the Asia-Pacific region is expected to grow the fastest. Applications of artificial intelligence in radiology and the demand for CT scans are driving market growth. Deep learning and computer vision are the primary technologies, with breast imaging and orthopedic applications being dominant.